FDA NDC Directory · JSON-LD · Markdown

Ultramicrosize Griseofulvin

NDC 23155-863 · HUMAN PRESCRIPTION DRUG · TABLET

Generic nameGriseofulvin
Labeler / ManufacturerHeritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc
Marketing categoryAbbreviated NDA (generic) · App ANDA061996
Dosage form / routeTABLET · ORAL
Active ingredientsGRISEOFULVIN (125 mg/1)
Marketing started20230630
Package count1

External sources

Source: openFDA. Public-domain (CC0).